Investors



  • FOR INFORMATION ON
    REPORTING CHANGES AND
    REVISED REVENUE GUIDANCE click here.


  • FOR GIVEN IMAGING
    ACQUISITION INFORMATION, click here.


  • FOR 2013 INVESTOR DAY MATERIALS,
    click here.


  • For Pharmaceuticals
    spin-off information,
    click here.


  • For tax basis information
    due to the Mallinckrodt spin,
    click here.


2014 News Releases

Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
DateTitle 
04/14/14Covidien Announces U.S. Food and Drug Administration 510(k) Clearance for the Kangaroo™ Feeding Tube with IRIS TechnologyPrinter Friendly Version
04/11/14Covidien Implements Voluntary Recall of its Pipeline™ Embolization Device and Alligator™ Retrieval DevicePrinter Friendly Version
03/28/14AORN Foundation, Covidien Team to Offer New Tools for Emerging Nurse LeadersPrinter Friendly Version
03/25/14Study Published in JAMA Shows Covidien Endoscopic Ablation Therapy Effective In Treating Barrett’s EsophagusPrinter Friendly Version
03/19/14Covidien Announces Results from 2014 Annual General MeetingPrinter Friendly Version
03/19/14Covidien Declares Quarterly Cash DividendPrinter Friendly Version
03/14/14Covidien plc to Report Second-Quarter Fiscal 2014 Results on April 25, 2014Printer Friendly Version
03/13/14Covidien Launches Symbotex™ Composite Mesh for Surgical Laparoscopic and Open Ventral Hernia RepairPrinter Friendly Version
03/06/14Covidien to Present at Barclays Global Healthcare Conference 2014Printer Friendly Version
03/03/14Covidien Announces CE Mark Approval for Puritan Bennett™ 980 VentilatorPrinter Friendly Version
02/27/14Covidien Completes Acquisition of Given ImagingPrinter Friendly Version
02/26/14Covidien Announces U.S. Food and Drug Administration 510(k) Clearance for the Puritan Bennett™ 980 VentilatorPrinter Friendly Version
02/24/14Covidien to Present at Raymond James 35th Annual Institutional Investors ConferencePrinter Friendly Version
02/18/14Covidien to Present at Upcoming Investor ConferencesPrinter Friendly Version
02/06/14Covidien Receives U.S. FDA 510(k) Clearance for Reinforced Stapling Reload TechnologyPrinter Friendly Version
02/04/14Covidien to Present at 2014 Leerink Global Healthcare ConferencePrinter Friendly Version
01/27/14Covidien Receives Japanese Regulatory Approval for Reinforced Stapling Reload TechnologyPrinter Friendly Version
01/27/14Covidien Chief Financial Officer Charles Dockendorff to Retire at End of YearPrinter Friendly Version
01/24/14Covidien Reports First-Quarter Fiscal 2014 ResultsPrinter Friendly Version
01/23/14Court Rules in Favor of Covidien in Ethicon Patent Infringement LawsuitPrinter Friendly Version
01/23/14Covidien Launches Advanced Medical Training and Education Center in IndiaPrinter Friendly Version
01/22/14Covidien Receives U.S. Food and Drug Administration Clearance for LigaSure™ Maryland JawPrinter Friendly Version
01/21/14Covidien to Exit OneShot™ Renal Denervation ProgramPrinter Friendly Version
01/16/14Covidien Declares Quarterly Cash DividendPrinter Friendly Version
01/15/14Covidien Completes Sale of Confluent Surgical to Integra LifeSciencesPrinter Friendly Version
01/13/14Covidien Announces Transactions Aimed at Emerging Markets ‘Value Segment’Printer Friendly Version
01/09/14Covidien, Lightstone Ventures, New Enterprise Associates Announce Series A Investment in FIRE1Printer Friendly Version

Stock Quote

COV (Common Stock)
ExchangeNYSE
(US Dollar)
Price$69.86
Change (%) Stock is Up 0.02
 (0.03%)
Volume1,996,576
As of 04/17/14 4:07 p.m. ET
Minimum 20 minute delay
Refresh quote

Tool Kit

Printer Friendly Version    Printer-friendly version
E-mail this page   E-mail this page
RSS    RSS Feeds
E-mail Alerts Receive E-mail Alerts
View contacts     View contacts